Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...
Please provide your email address to receive an email when new articles are posted on . The future for presbyopia is bright no matter what side you are on. For drops, the benefits are that they are ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform1-6 Clareon Vivity joins ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European ...
Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...
Patients who have a new type of lens implanted in their eyes during surgery for cataracts or to correct their eyesight have excellent or good vision over distances both near and far, and often no ...
BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...
Cataract surgery is one of the most successful medical procedures performed in the United States, with nearly 4 million Americans choosing to have their cataracts removed every year. While the ...
—There is no perfect intraocular lens, but matching a patient with the lens that best meets their needs can help reduce postoperative dissatisfaction. Reviewed by Sarju Patel, MD, MPH, MSc, Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results